Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Production of Formed Elements01:34

Production of Formed Elements

Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lipid-lowering therapy after finding high Lp(a)-adding ezetimibe or intensifying statin treatment?

Journal of clinical lipidology·2026
Same author

Lipoprotein(a) levels in Finnish adults: distribution and associations with other cardiovascular risk factors and their awareness and control.

Lipids in health and disease·2026
Same author

Ezetimibe alone for over 75 years old as a primary prevention to decrease cardiovascular events.

Annals of medicine·2026
Same author

Calibration of Flow Cytometers Enables Reproducible Measurements of Extracellular Vesicle Concentrations and Reference Range Establishment.

Journal of extracellular vesicles·2025
Same author

Icosapent ethyl-induced lipoprotein remodeling and its impact on cardiovascular disease risk markers in normolipidemic individuals.

JCI insight·2025
Same author

Tissue-Resident Myeloid and Histiocytic Cells in Health and Disease: Novel Emerging Concepts.

American journal of hematology·2025

Related Experiment Video

Updated: May 12, 2026

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells
10:25

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells

Published on: August 9, 2019

Human mast cells arise from a common circulating progenitor.

Katariina Maaninka1, Jani Lappalainen, Petri T Kovanen

  • 1Wihuri Research Institute, Helsinki, Finland.

The Journal of Allergy and Clinical Immunology
|April 16, 2013
PubMed
Summary

Human mast cells (MCs) originate from a common progenitor. All circulating MC progenitors can differentiate into MCs expressing a full panel of neutral granule proteases, revealing MC heterogeneity.

Keywords:
CPA3Carboxypeptidase A3ChymaseKITLGKit ligandMCMC(T)MC(TC)MITFMast cellMast cell containing tryptaseMast cell containing tryptase and chymaseMicrophthalmia transcription factorkit ligandmast cellneutral granule proteasetryptase

More Related Videos

Isolation of Blood-vessel-derived Multipotent Precursors from Human Skeletal Muscle
10:52

Isolation of Blood-vessel-derived Multipotent Precursors from Human Skeletal Muscle

Published on: August 21, 2014

Identification and Isolation of Oligopotent and Lineage-committed Myeloid Progenitors from Mouse Bone Marrow
07:21

Identification and Isolation of Oligopotent and Lineage-committed Myeloid Progenitors from Mouse Bone Marrow

Published on: July 29, 2018

Related Experiment Videos

Last Updated: May 12, 2026

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells
10:25

Pan-myeloid Differentiation of Human Cord Blood Derived CD34+ Hematopoietic Stem and Progenitor Cells

Published on: August 9, 2019

Isolation of Blood-vessel-derived Multipotent Precursors from Human Skeletal Muscle
10:52

Isolation of Blood-vessel-derived Multipotent Precursors from Human Skeletal Muscle

Published on: August 21, 2014

Identification and Isolation of Oligopotent and Lineage-committed Myeloid Progenitors from Mouse Bone Marrow
07:21

Identification and Isolation of Oligopotent and Lineage-committed Myeloid Progenitors from Mouse Bone Marrow

Published on: July 29, 2018

Area of Science:

  • Immunology
  • Cell Biology
  • Hematology

Background:

  • Human mast cells (MCs) exhibit phenotypic heterogeneity marked by neutral granule proteases.
  • Previous understanding limited MC phenotypes to tryptase-only or tryptase/chymase expressing cells.
  • The developmental relationship between MCs with different protease profiles remained unclear.

Purpose of the Study:

  • To investigate the relationship between human mast cells (MCs) with distinct protease phenotypes and their circulating progenitors.
  • To elucidate the differentiation potential of MC progenitors.

Main Methods:

  • Human peripheral blood CD34(+) progenitors were cultured with kit ligand (KITLG) and cytokines (IL-3, IL-9, IL-6) or KITLG alone.
  • Expression of key proteases (chymase, CPA3, cathepsin G, granzyme B, tryptases) was assessed at mRNA and protein levels.

Main Results:

  • Culture with KITLG and cytokines generated a uniform MC population expressing tryptase, chymase, CPA3, cathepsin G, and granzyme B.
  • KITLG alone was sufficient to induce the expression of all tested proteases in differentiating MCs.

Conclusions:

  • All circulating human MC progenitors can differentiate into MCs expressing a complete set of neutral granule proteases.
  • This suggests a common MC-committed progenitor for all human MC phenotypes.